Author:
Santoro Nanette F.,Kovacs Peter
Reference86 articles.
1. Lumsden MA, West CP, Baird DT. Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids. Clin Endocrinol 1989; 31: 335–343.
2. Lahti E, Vuopala S, Kauppila A, Blanco G, Ruokonen A, Laatikainen T. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Gynecol Oncol 1994; 55: 410–414.
3. Willis KJ, London DR, Ward HWC, Butt WR, Lynch SS, Rudd BT. Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course. BMJ 1977; 1: 425–428.
4. Cohen CJ. Tamoxifen and endometrial cancer: tamoxifen effects on the human female genital tract. Semin Oncol 24(suppll): S1: 55–64.
5. Sherman BM, Chapler FK, Crickard K, Wycoff D. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 1979; 64: 398–404.